Clinical significance of serum transforming growth factor-β1 in lung cancer

• Published in: Cancer epidemiology Vol. 37; no. 5; pp. 750 - 753
• Main Authors: Hou, Yu-Lei, Chen, Hui, Dong, Zi-He, Xue, Cheng-Jun, Wu, Yan-Feng, Luo, Hai-Xia, Wu, Yong-Chang, Li, Cheng-Hua
• Format: Journal Article
• Language: English
• Published: Amsterdam Elsevier Ltd 01.10.2013; Elsevier
• Subjects: Adult; Aged; Analysis. Health state; Biological and medical sciences; Biomarkers, Tumor - blood; Case-Control Studies; ELISA; Enzyme-Linked Immunosorbent Assay; Epidemiology; Female; General aspects; Hematology, Oncology and Palliative Medicine; Humans; Internal Medicine; Lung cancer; Lung Neoplasms - blood; Lung Neoplasms - pathology; Male; Medical sciences; Middle Aged; Neoplasm Staging; Public health. Hygiene; Public health. Hygiene-occupational medicine; ROC Curve; Transforming Growth Factor beta1 - blood; Transforming growth factor β1; Tumors; Lung cancer; Transforming growth factor β1; ELISA; Lung disease; Respiratory disease; Bronchus disease; Serum; Malignant tumor; Enzyme immunoassay; ELISA assay; Cancer

Background: Transforming growth factor-β1 (TGF-β1) plays a critical role in human cancer development. Present study aimed to explore the clinical significance of serum TGF-β1 levels in patients with lung cancer and analyze the relationship between TGF-β1 and existing tumor markers for lung cancer. M...